Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry

興科蓉醫藥(06833.HK):成都天府國際生物城管理委員會支持其智能醫美項目
Xingke Rong Medicine (06833.HK): Chengdu Tianfu International Biological City Management Committee supports its intelligent medical beauty project.

即市頭條 ·  {{timeTz}}

興科蓉醫藥(06833.HK)公布,成都天府國際生物城管理委員會表示全力支持公司的智能醫美產業園項目及其對聚己內酯等醫美產品的研究及發展和產業化,委 員會將為公司醫美產業園項目及這些醫美產品的研究及發展和產業化提供良好的營商環境、優質高效的政務服務,並在資源和人才方面給予支持。

Xingke Rong Pharmaceutical (06833.HK) announced that the Chengdu Tianfu International Biological City Management Committee expressed its full support for the company's intelligent medical beauty industrial park project and its research, development and industrialization of polycaprolactone and other medical beauty products. The committee will provide a good business environment, quality and efficient government services for the company's medical beauty industrial park project and the research, development and industrialization of these medical beauty products. And give support in terms of resources and talents.

公司表示,委員會表示將協助公司於醫美產品領域建立重要研究及發展策源地及產業化基地,公司將就成 都醫美產業園項目與委員會及相關政府機關積極合作。

The company said that the committee will assist the company in establishing an important research and development source and industrialization base in the field of medical and beauty products, and the company will actively cooperate with the committee and relevant government agencies on the Chengdu Medical and Beauty Industrial Park project.

This page is machine-translated. Moomoo tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal.


Moomoo is a financial information and trading app offered by Moomoo Techonologies Inc.


In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).


In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. ("Moomoo Financial SG") regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial SG is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.


In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.